Cytokine (IL-10 -1082 and -819) and chemokine receptor (CCR2 and CCR5) gene polymorphism in North Indian Patients with end-stage renal disease

DNA and Cell Biology

Volumn 28, Issue 4, 2009, Pages 177-183

  Manchanda, Parmeet Kaur ^a   Singh, Ranjana ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; INTERLEUKIN 10; CCR2 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR5; IL10 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; CHRONIC KIDNEY FAILURE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; INTERLEUKIN-10; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RECEPTORS, CCR2; RECEPTORS, CCR5; YOUNG ADULT;

EID: 64549112945     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0822     Document Type: Article

References (36)

1. Chin, H.J., Na, K.Y., Kim, S.J., Oh, K.H., Kim, Y.S., Lim, C.S., Kim, S., and Chae, D.W. (2005). Interleukin-10 promoter polymorphism is associated with the predisposition to the development of IgA nephropathy and focal segmental glomerulosclerosis in Korea. J Korean Med Sci 20, 989-993.
2. Choi, Y.K., Kim, Y.J., Park, H.S., Choi, K., Paik, S.G., Lee, Y.I., and Park, J.G. (2003). Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney. Gene Ther 10, 559-568.
3. Coelho, A., Matos, A., Catarino, R., Pinto, D., Pereira, D., Lopes, C., and Medeiros, R. (2005). Protective role of the polymorphism CCR2-64I in the progression from squamous in-traepithelial lesions to invasive cervical carcinoma. Gynecol Oncol 96, 760-764.
4. de Lema, G.P., Maier, H., Nieto, E., Vielhauer, V., Luckow, B., Mampaso, F., and Schlöndorff, D. (2001). Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 12, 1369-1382.
5. Eskdale, J., Kube, D., Tesch, H., and Gallagher, G. (1997). Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 46, 120-128.
6. Gauderman, W.J. (2002). Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155, 478-484.
7. Gérard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., and Velu, T. (1993). Interleukin10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177, 547-550.
8. Giordani, L., Bruzzi, P., Lasalandra, C., Quaranta, M., Schittulli, F., Della Ragione, F., and Iolascon, A. (2003). Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin Chem 49, 1664-1667.
9. González, P., Alvarez, R., Batalla, A., Reguero, J.R., Alvarez, V., Astudillo, A., Cubero, G.I., Cortina, A., and Coto, E. (2001). Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes Immun 2, 191-195.
10. Huang, X.R., Kitching, A.R., Tipping, P.G., and Holdsworth, S.R. (2000). Interleukin-10 inhibits macrophage-induced glomeru-lar injury. J Am Soc Nephrol 11, 262-269.
11. Ioannidis, J.P., Rosenberg, P.S., Goedert, J.J., Ashton, L.J., Ben-field, T.L., Buchbinder, S.P., Coutinho, R.A., Eugen-Olsen, J., Gallart, T., Katzenstein, T.L., Kostrikis, L.G., Kuipers, H., Louie, L.G., Mallal, S.A., Margolick, J.B., Martinez, O.P., Meyer, L., Michael, N.L., Operskalski, E., Pantaleo, G., Rizzardi, G.P., Schuitemaker, H., Sheppard, H.W., Stewart, G.J., Theodorou, I.D., Ullum, H., Vicenzi, E., Vlahov, D., Wilkinson, D., Workman, C., Zagury, J.F., and O'Brien, T.R.; International Meta-Analysis of HIV Host Genetics. (2001). Effects of CCR5-D32, CCR2-64I, and SDF-1 3′A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann Intern Med 135, 782-795.
12. Kitching, A.R., Katerelos, M., Mudge, S.J., Tipping, P.G., Power, D.A., and Holdsworth, S.R. (2002). Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis. Clin Exp Immunol 128, 36-43.
13. Kittles, R.A., and Weiss, K.M. (2003). Race, ancestry, and genes: implications for defining disease risk. Annu Rev Genomics Hum Genet 4, 33-67.
14. Luster, A.D. (1998). Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338, 436-445.
15. Manchanda, P.K., Kumar, A., Bid, H.K., and Mittal, R.D. (2006a). Interleukin-1beta and receptor antagonist (IL-1Ra) gene polymorphisms and the prediction of the risk of end-stage renal disease. Biomarkers 11, 164-173.
16. Manchanda, P.K., Kumar, A., Kaul, A., and Mittal, R.D. (2006b). Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India. Clin Chim Acta 370, 152-157.
17. Miller, S.A., Dykes, D.D., and Polesky, H.F. (1998). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 11, 1215.
18. Mittal, R.D., and Manchanda, P.K. (2007a). Association of in-terleukin (IL)-4 intron-3 and IL-6-174 G/C gene polymorphism with susceptibility to end-stage renal disease. Immunogenetics 59, 159-165.
19. Mittal, R.D., and Manchanda, P.K. (2007b). Is low frequency distribution of TGF-β genotype associated with increased risk for end stage renal disease? DNA Cell Biol 26, 172-177.
20. Mu, W., Ouyang, X., Agarwal, A., Zhang, L., Long, D.A., Cruz, P.E., Roncal, C.A., Glushakova, O.Y., Chiodo, V.A., Atkinson, M.A., Hauswirth, W.W., Flotte, T.R., Rodriguez-Iturbe, B., and Johnson, R.J. (2005). IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 16, 3651-3660.
21. Munerato, P., Azevedo, M.L., Sucupira, M.C., Pardini, R., Pinto, G.H., Catroxo, M., Souza, I.E., and Diaz, R.S. (2003). Frequency of polymorphisms of genes coding for HIV-1 co-receptors CCR5 and CCR2 in a Brazilian population. Braz J Infect Dis 7, 236-240.
22. Park, S.H., Kang, K.J., Song, Y.R., Chae, D.W., Oh, K.H., and Kim, S.G. (2002). The impact of gene polymorphism of interleulin-10 and interferon-gammaonthe clinical coursesof renal transplant patients in Korea. Korean J Nephrol 21, 990-999.
23. Perrey, C., Turner, S.J., Pravica, V., Howell, W.M., and Hutchinson, IV. (1999). ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 7, 127-128.
24. Petit-Bertron, A.F., Pedron, T., Gross, U., Coppee, J.Y., Sanso-netti, P.J., Cavaillon, J.M., and Adib-Conquy, M. (2005). Adherence modifies the regulation of gene expression induced by interleukin-10. Cytokine 29, 1-12.
25. Prasad, P., Tiwari, A.K., Kumar, K.M., Ammini, A.C., Gupta, A., Gupta, R., and Thelma, B.K. (2007). Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet 8, 20-25.
26. Romagnani, S. (2000). T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85, 9-21.
27. Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R.J., Collman, R.G., Doms, R.W., Vassart, G., and Parmentier, M. (1996). Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725.
28. Sankaran, D., Asderakis, A., Ashraf, S., Roberts, I.S., Short, C.D., Dyer, P.A., Sinnott, P.J., and Hutchinson IV. (1999). Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 56, 281-288.
29. Schlondorff, D., Nelson, P.J., Luckow, B., and Banas, B. (1997). Chemokines and renal disease. Kidney Int 51, 610-621.
30. Stenvinkel, P., Ketteler, M., Johnson, R.J., Lindholm, B., Pecoits-Filho, R., Riella, M., Heimbürger, O., Cederholm, T., and Girndt, M. (2005). Interleukin-10, IL-6 and TNF-a: important factors in the altered cytokine network of end-stage renal disease - the good, the bad and the ugly. Kidney Int 67, 1216-1233.
31. Turner, D.M., Williams, D.M., Sankaran, D., Lazarus, M., Sin-nott, P.J., and Hutchinson, IV. (1997). An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24, 1-8.
32. Uitterlinden, A.G., Fang, Y., Van Meurs, J.B., Pols, H.A., and Van Leeuwen, J.P. (2004). Genetics and biology of vitamin D receptor polymorphisms. Gene 338, 143-156.
33. Wada, T., Yokoyama, H., and Kobayashi, K. (2000). Chemokines new target molecules in renal diseases. Clin Exp Nephrol 4, 273-280.
34. Yao, Q., Lindholm, B., and Stenvinkel, P. (2004). Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients. Hemodial Int 8, 118-129.
35. Zeisberg, M., Strutz, F., and Müller, G.A. (2000). Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol 3, 111-120.
36. Zlotnik, A., and Yoshie, O. (2000). Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127.